BACKGROUND/OBJECTIVES: Although weight loss has been associated with changes in circulating 25-hydroxyvitamin D (25(OH) D) levels, the quantification of the increase in 25(OH)D levels as a function of adipose tissue volume loss precisely assessed by imaging has not been reported before. The objective of this substudy was to describe the effects of a 1-year lifestyle intervention on plasma 25(OH)D levels. The relationships between changes in 25(OH)D levels and changes in adiposity volume (total and by adipose tissue compartment) were studied. SUBJECTS/METHODS: This intervention study was performed between 2004 and 2006 and participants were recruited from the general community. Sedentary, abdominally obese and dyslipidemic men (n = 103) were involved in a 1-year lifestyle modification program. Subjects were individually counseled by a kinesiologist and a nutritionist once every 2 weeks during the first 4 months with subsequent monthly visits in order to elicit a 500-kcal daily energy deficit and to increase physical activity/exercise habits. Body weight, body composition and fat distribution were assessed by dual-energy X-ray absorptiometry and computed tomography, whereas the 25(OH)D levels were measured with an automated assay. RESULTS: The 1-year intervention resulted in a 26% increase in circulating 25(OH)D (from 48 ± 2 nmol l − 1 or 19 ± 0.8 ng ml − 1 (± s.e.m.) to 58 ±2 nmol l − 1 or 23 ± 0.8 ng ml − 1 , P o0.0001) along with a 26% decrease in visceral adiposity volume (from 1947 ± 458 to 1459 ± 532 cm 3 ). One-year increases in 25(OH)D levels correlated inversely with changes in all adiposity indices, especially Δvisceral (r = − 0.36, Po 0.0005) and Δtotal abdominal (r = − 0.37, P o 0.0005) adipose tissue volumes. CONCLUSIONS: These results indicate that there is a linear increase in circulating 25(OH)D levels as a function of adiposity volume loss, and therefore suggest a role of adiposity reduction in the management of obesity-associated vitamin D insufficiency.
INTRODUCTION
Vitamin D (25(OH)D) insufficiency and obesity are two prevalent health conditions worldwide. 1, 2 Obesity is a recognized risk factor for low 25(OH)D status as shown by the high prevalence of 25(OH)D insufficiency among obese individuals. 3 Because of the lipophilic nature of 25(OH)D, it has been suggested that obesityassociated vitamin D insufficiency may be due to the decreased bioavailability of vitamin D obtained from cutaneous and dietary sources secondary to its deposition and sequestration in body fat compartments. 4 More recently, volumetric dilution has been suggested as the mechanism underlying low 25(OH)D in obesity, 5 a mechanism that has been validated in an independent study. 6 Other mechanisms have been proposed for low 25 (OH)D levels in obesity, such as the lack of sun exposure due to the social stigma and decreased mobility of obesity and inhibition of the 25-hydroxylation of vitamins D2 and D3 by elevated circulating 1,25(OH)D. 7 Cross-sectional studies have already established a negative correlation between abdominal adiposity, particularly visceral adipose tissue (VAT), and circulating 25(OH)D levels. 8, 9 However, to the best of our knowledge, no intervention study has yet quantified the contribution of the reduction in adiposity by means of a lifestyle modification program, without supplementation, to the improvement of circulating vitamin D levels.
In order to quantify the contribution of an adiposity volume reduction to changes in the circulating levels of 25(OH)D, we studied a sample of non-vitamin D-supplemented men before and after a 1-year lifestyle modification program aiming at improving nutritional quality and increasing physical activity/exercise level. The SYNERGIE lifestyle intervention consisted of regular physical activity/exercise combined with the implementation of a healthy diet. We have previously reported that, at the 1-year follow-up visit, participants significantly decreased their volume of VAT and improved their glucose-tolerance status 10, 11 while improving their lipid profile. 12 The present substudy aimed at investigating the relationships between the lifestyle intervention and the vitamin D status. Our specific objectives were as follows: (1) to quantify the 25(OH)D change as a result of adiposity loss mediated by a lifestyle intervention and (2) to determine which body fat distribution/anthropometric parameters (for example, VAT, subcutaneous adipose tissue (SAT), fat mass and so on) is the most related to the circulating 25(OH)D levels.
SUBJECTS AND METHODS Subjects
One hundred and three French Canadian (Caucasian) men participating in the SYNERGIE lifestyle intervention were included in the present post hoc analyses. Men between 30 and 65 years, presenting abdominal obesity (waist circumference ⩾ 90 cm), triglyceride levels ⩾ 1.69 mmol l − 1 (⩾150 mg dl − 1 ) and/or high-density lipoprotein cholesterol o1.03 mmoll − 1 ( o40 mg dl − 1 ) were recruited by solicitation in the media to participate in a lifestyle modification program (the SYNERGIE study). The SYNERGIE intervention consisted of up to 14 visits with a dietician and a kinesiologist over a 1-year period of time (see 'Intervention' section below). Subjects with type 2 diabetes, body mass index values o25 or 440 kg m − 2 , taking medication targeting glucose metabolism, lipid metabolism or blood pressure management were excluded. Only participants with baseline and 1-year plasma samples were included in the present analyses. The participants for whom the measurement of 25(OH)D was not available did not differ from the participants with 25(OH) D data in terms of baseline anthropometry, lipid profile, glucose homeostasis profile and inflammation profile. Informed consent was obtained from all the participants. This study was approved by the Medical Ethics Committees of Université Laval and the Institut universitaire de cardiologie et de pneumologie de Québec.
Intervention
The SYNERGIE program was a combined nutritional and physical activity intervention. The study design has been described previously. 10, 11 In brief, the subjects were individually counseled once every 2 weeks during the first 4 months of the intervention with subsequent monthly visits to progressively improve their nutritional and physical activity/exercise habits. Each visit included an interactive session with a registered dietician followed by a meeting with a kinesiologist. The goal of the nutritional counseling was to reduce calorie consumption by 500 kcal per day during the first year. The physical activity program aimed to reach 160 min per week of moderate-intensity endurance exercise. Men received a personalized training program, had free access to on-site fitness center and were allowed to perform exercise on-or off-site at their convenience. Participants were asked to wear a pedometer and to reach a target of 10 000 daily steps.
Diet
The diet and the nutritional quality assessment was described in detailed previously. 13 In summary, participants completed a 3-day dietary record including a nonworking day both at the initial visit and at the 1-year follow-up to quantify the overall nutritional quality. Two trained dieticians reviewed the record, reported quantities as well as the type of food and cross-validated the data. A DASH-derived diet quality score was calculated for each participant at each visit. 13 Standardized serving sizes were evaluated according to the Canada's Food Guide.
Exercise and cardiorespiratory fitness assessment
Supervised and unsupervised exercise sessions as well as the mean number of daily steps were recorded daily in a diary by each participant. A submaximal treadmill standardized exercise test was used to assess the cardiorespiratory fitness using, as an index, the subjects' heart rate (mean of the last 3 min) at a standardized submaximal treadmill workload (3.5 m h − 1 , 2% slope). 10, 11 Anthropometry, body composition and adiposity mapping Height, weight, hip and waist circumferences were measured according to the standardized procedures. 14, 15 Dual-energy X-ray absorptiometry (Lunar Prodigy, GE Healthcare, Madison, WI, USA) was used to assess fat mass and fat-free mass. VAT and SAT cross-sectional areas were assessed by computed tomography, using previously described procedures. 16, 17 Calculations of the partial volumes of VAT and SAT between L2-L3 and L4-L5 were performed using the product of the mean of L2-L3 and L4-L5 cross-sectional areas multiplied by the distance separating the two slices, as previously described. 18 
25(OH)D measurement
Plasma samples were collected after an overnight fast at the initial visit as well as at the 1-year visit. Plasma was collected in EDTA vacutainers and stored at − 80°C, 25(OH)D being stable for up to 24 years when stored at − 70°C. 19 The Vitamin D total assay from Roche was used and measurements were performed in batch on a MODULAR ANALYTICS E170 (Roche Diagnostics, Mannheim, Germany). This automated assay is based on the competition between labeled vitamin D from the assay and nonlabeled vitamin D in the plasma (D2 and D3) for binding to vitamin D-binding protein. The Roche Vitamin D total assay is standardized to a liquid chromatography-mass spectrometry method, itself standardized against the NIST Standard Reference Material 972. Method comparison demonstrated good agreement between the results of the assay and those obtained from liquid chromatography-mass spectrometry. Circulating 25 (OH)D levels at baseline and at the 1-year visit were adjusted for the season of venipuncture (winter = January, February and March; spring = April, May and June; summer = July, August, September and autumn = October, November and December). The 1-year variation in 25(OH)D was not adjusted for season as the elapsed time between the baseline visit and the 1-year follow-up was 1 year plus 2-6 weeks for all the participants. Sun exposure as well as sunscreen use was not documented.
Plasma lipids, lipoproteins and inflammation markers
Plasma high-density lipoprotein cholesterol, triglycerides, very low-density lipoprotein cholesterol, low-density lipoprotein cholesterol and apolipoprotein B and AI were determined according to the standardized procedure. [20] [21] [22] [23] Plasma interleukin-6 and tumor necrosis factor-α concentrations were measured by ELISA (R&D Systems, Minneapolis, MN, USA). Plasma highly sensitive C-reactive protein concentrations were determined by immunonephelometry (Dade Behring, Marburg, Germany) and participants with values 410 mg l − 1 were excluded from the analyses. Concentrations of plasma plasminogen activator inhibitor-1 were measured by ELISA (Diagnostica Stago, Asnières-sur-Seine, France).
Statistical analysis
Values reported in Table 1 are means ± s.d. except for 25(OH)D, which are means of season-adjusted 25(OH)D ± s.e.m. for the baseline visit and the 1-year follow-up. Paired t-tests were used to assess the statistical significance of change of variables over the first year of the lifestyle modification program. Pearson correlation coefficients were calculated to quantify the univariate associations between changes in 25(OH)D and changes in anthropometric, lipoprotein-lipid (total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglyceride and apolipoproteins AI and B), inflammation (tumor necrosis factor-α, interleukin-6, plasminogen activator inhibitor-1 and highly sensitive C-reactive protein) and diet (DASH-derived diet quality score, fatty fish consumption and dairy product consumption) variables. Moreover, a Pearson partial correlation coefficient (adjusted for changes in VAT volume) was computed between changes in 25(OH)D and changes in triglyceride concentrations. Multivariate stepwise regression analyses were performed to quantify the independent contributions of changes in VAT and SAT volumes to the variance in 25(OH)D changes. Values presented in Figure 2 are means ± s.e.m., with P-values obtained from analysis of variance. Shapiro-Wilk test was used to examine the distribution of statistical model. The results were considered significant with P-values ⩽ 0.05. All analyses were conducted using SAS 9.2 (Cary, NC, USA). Table 1 shows the baseline and 1-year characteristics of the 103 men who took part in the SYNERGIE lifestyle modification program (baseline age = 48 ± 9 years). Participants increased their circulating plasma levels of 25(OH)D by 10 nmol l − 1 (4 ng ml − 1 ) without supplementation (from 48 ± 2 nmol l − 1 (19 ± 0.8 ng ml − 1 ) to 58 ± 2 nmol l − 1 (23 ± 0.8 ng ml − 1 ) (± s.e.m.), Po 0.0001). They also decreased their anthropometric indices as well as adipose tissue volume. In linear regression analyses, 1-year changes in circulating 25(OH)D levels (Δ25(OH)D) correlated inversely with changes in all anthropometric parameters, especially the 1-year changes in visceral (r = −0.36; P o0.0005) and total abdominal (r = -0.37; Po 0.0005) adipose tissue volumes ( Figure 1 ). Changes in diet parameters (1- year changes in global diet score, fatty fish consumption and dairy product consumption) were not associated with circulating 25(OH)D changes (results not shown). Changes in lipid profile and inflammation markers: no association with changes in 25(OH)D levels No association was found between 1-year changes in lipid profile (total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and apolipoproteins AI and B) and inflammation markers (tumor necrosis factor-α, interleukin-6, plasminogen activator inhibitor-1 and highly sensitive C-reactive protein) and 1-year increases in 25(OH)D levels. Changes in triglycerides seemed to be associated with Δ25(OH)D in univariate analysis but once the model had been adjusted for changes in visceral adiposity, the association was no longer significant (results not shown).
RESULTS

Effect of the lifestyle modification program on plasma 25(OH)D levels and other markers
DISCUSSION
The main findings of this substudy are (1) that the loss of adiposity mediated by a lifestyle intervention was associated with a proportional increase in circulating 25(OH)D levels; (2) changes in diet could not explain the changes in 25(OH)D levels and (3) that the adipose tissue compartment that had the highest impact on circulating 25(OH)D levels was VAT.
Contribution of the current results to the literature The negative association between adiposity and 25(OH)D levels has already been documented in cross-sectional studies performed in Caucasian American, 24 Hispanic American, 25 African American, 25 European, 9 South Asian 9 and French Canadian 8 populations.
The present study provides further evidence in an intervention study that the reduction in adiposity, especially in VAT, is associated with an increase in circulating levels of 25(OH)D in nonsupplemented abdominally obese patients, supporting a physiological link between adiposity and 25(OH)D. Rock et al. 26 had previously reported that women experiencing a greater weight loss over a 24-month period had a more substantial increase in their circulating 25(OH)D levels. Although the authors suggested that this increase in 25(OH)D was due to the loss in adiposity, they did not have the data to test the possibility that some regional adipose depots could contribute more to the 25(OH)D change than others. The cross-sectional study of Sulistyoningrum et al. 9 reported that the 25(OH)D levels were inversely associated with body mass index, waist circumference, VAT, SAT and percent fat mass. They also showed in a regression model including VAT, SAT and percent fat mass that only VAT was independently and negatively associated with 25(OH)D levels. 9 This observation goes along with the higher reported content of vitamin D in VAT, more precisely 19% more vitamin D3 measured in VAT as compared with SAT. 6 Our observations extend such a relationship further by showing that the 1-year reduction of VAT (−26%) was proportionally associated with the 1-year increase in 25(OH)D levels (+26%), and that VAT was the adipose depot that had the most impact on 25(OH)D levels. We also show that variation in all adiposity variables are inversely related to the changes in 25(OH)D levels. Adiposity therefore appears to be one of the key modulators of 25(OH)D levels. Considering the modest variance (13%) shared by changes in VAT 
Body composition
Fat mass (kg) 28.9 ± 6.6 23.0 ± 6.9 − 5.9 ± 3.8 The impact of adiposity loss on 25(OH)D levels has also been studied in populations of patients who underwent bariatric surgery procedures such as the Roux-en-Y gastric bypass. 6, 27 Measurements of vitamin D2 and D3 content from different adipose depots, such as omentum, VAT and SAT, obtained per-operatively were described. The study of Beckman et al. 6 suggested that VAT was an important vitamin D3 depot, a finding that supports our observation that VAT might be the adipose tissue depot that has the most impact on one's vitamin D status. However, bariatric populations are not comparable to our study sample in several aspects including the mechanism of weight loss (surgery vs lifestyle), the presence of vitamin D supplementation (supplemented vs nonsupplemented) and the degree of initial adiposity (massive obesity in the surgical weight loss study vs moderate obesity in the present study as our average initial body mass index was nearly 31 kg m − 2 ). Moreover, Roux-en-Y gastric bypass leads to malabsorption and to an adiposity loss accompanied by lean mass loss, both phenomena (malabsorption and lean mass loss) not being observed in our sample who simply improved their diet and exercised to achieve weight loss. Pramyothin et al. 27 reported that despite a dramatic decline in body fat mass after Roux-en-Y gastric bypass and vitamin D supplementation, adipose tissue vitamin D did not significantly contribute to vitamin D status in the postoperative period. This finding is neither supported by the study of Beckman et al., 6 who observed an improvement of vitamin D status on a similar bariatric population, nor by our study where we found a linear increase in 25(OH)D levels as a function of VAT loss without vitamin D supplementation.
Possible mechanisms of low 25(OH)D in obesity and improvement of 25(OH)D levels with adiposity loss As previously mentioned, low 25(OH)D status in obesity has been well documented in a number of studies. 3, 8, 9, [24] [25] [26] Sequestration 4 as well as volumetric dilution 5 of vitamins D2 and D3 are mechanisms that have been proposed to explain low circulating 25(OH)D concentrations observed in the obese state. Sequestration of vitamins D2 and D3 not only refers to the hydrophobic nature of these nutrients and their propensity to dissolve in fat, but also to the unavailability of these vitamins once stored in fat for their retrieval and their hepatic 25-hydroxylation to replenish the pool of circulating 25(OH)D. Volumetric dilution of ingested or cutaneously synthesized vitamin D into the different adipose depots implies that a larger total adipose volume leads to a larger volume of distribution, which in turn leads to decreased concentrations of vitamins D2 and D3 in the blood stream for their 25-hydroxylation in liver, resulting in lower 25(OH)D levels. The initial study supporting the volumetric dilution model of vitamins D2 and D3 was a population-based cross-sectional analysis of 25(OH)D levels as a function of body weight. Serum 25 (OH)D (nmol l − 1 ) and weight (kg) were fitted into a hyperbolic model, a function that is the mathematical representation of the relationship between concentration and volume. Beckman et al. 6 further validated the volumetric dilution model by using the same hyperbolic function with weight and 25(OH)D levels obtained from 20 women who underwent bariatric surgery. Of note, in both studies, ranges of weight, fat mass and 25(OH)D values were wider than that in the present study and included extreme weights, revealing the hyperbolic relationship linking 25 (OH)D levels to weight and fat mass. The hyperbolic relationship between weight and 25(OH)D was not clearly established in our cohort and several reasons might explain this fact. A first possibility is that the intervention modified the metabolism of 25 (OH)D. No data were collected on parameters reflecting its bioactivation (1,25(OH)D levels) or its disposition (24, 25 (OH)D excretion). Another possibility is that the range of weight and weight loss (from 94.2 ± 11.5 to 87.5 ± 11.3 kg) was too narrow to observe the hyperbolic trend. Weight is a composite of both lean mass and fat mass, and in the context of a lifestyle intervention study, lean mass is preserved or even enhanced by physical training, whereas fat mass is decreased. Therefore, weight is more prone to bias than volume of adipose tissue measured by imaging techniques when it comes to establishing the distribution volume of 25(OH)D. The present study contains data on different adipose tissue volume changes, which are more precise than weight changes. Although 25(OH)D did not follow a clear hyperbolic trend as a function of adiposity loss, the present findings support the volumetric dilution model. Participants in the lifestyle intervention program increased their circulating 25(OH)D proportionally to adiposity loss, without vitamin D2 or D3 supplementation, an observation that does not support sequestration and biological unavailability of vitamin D. Our results rather support the notion that for a given vitamin D exposure, the reduction of the distribution volume leads to an increase in 25(OH)D concentration. Our findings suggest that the normalization of adipose tissue volume would in turn lead to higher 25(OH)D levels in the otherwise healthy individuals.
Circulating 25(OH)D levels: a biomarker of global metabolic health? Excess visceral adiposity is associated with a dysmetabolic state and has been related to other metabolic abnormalities, such as insulin resistance, inflammation and a pro-atherogenic lipid phenotype. 28, 29 The observation that 25(OH)D increases linearly with visceral adiposity loss suggests that (1) low 25(OH)D levels in visceral obesity could be one more biomarker of a dysmetabolic state and therefore that (2) the mechanism by which a deficit in 25 (OH)D is addressed (supplements, visceral adiposity loss) should be thought carefully. Our results suggest that the optimal management of a 25(OH)D deficiency in visceral obesity should include a lifestyle intervention aiming at VAT normalization to correct 25(OH)D as well as other VAT-related metabolic disturbances. Vitamin D2 and D3 supplementation with dose regimen adjusted for the elevated distribution volume in obesity might effectively normalize 25(OH)D levels. An approach targeting visceral adiposity loss as a goal, with vitamin D3 supplementation, would not only result in normalization of 25(OH)D levels as a function of a smaller distribution volume, but would also promote the normalization of the lipid profile 12 and relief of insulin resistance. 11 Our data are consistent with the previously described positive associations between adequate circulating 25(OH)D levels, normal body weight and a healthy lifestyle. 30 Improvement of the quality of the diet: no association found with the improvement in 25(OH)D levels In our study, the lifestyle modification program resulted in a significant improvement in the overall quality of the diet including increased intake of foods containing vitamin D such as fatty fish and dairy products. 13 More precisely, the 1-year intervention resulted in a marked improvement of the integrative DASHderived diet quality score (P o0.0001) as described in Nazare et al. 13 Regarding foods susceptible to contain vitamin D2 or D3, dairy product consumption started at 1.66 ± 1.07 servings per day at baseline and ended at 2.10 ± 1.10 servings per day at 1 year (P o 0.01), whereas fish consumption corresponded to 0.29 ± 0.51 servings per day at baseline and increased to 0.41 ± 0.60 servings per day at 1 year. 13 In the present study, changes in these variables (1- year improvement in DASH-derived diet quality score, in fatty fish consumption and in dairy product consumption) were not significantly associated with the 1-year increase in 25(OH)D, underscoring that 25(OH)D changes cannot be explained by a better diet and reinforcing the previously reported observation that changes in the diet may not be a major contributor to the changes in 25(OH)D levels. 31, 32 Strengths and limitations An important strength of our study is that it was a prospective intervention trial with baseline and 1-year measurements of season-adjusted 25(OH)D levels, computed tomography imaging adiposity indices as well as assessment of diet. Such measurements have allowed the quantification of the individual contribution of each fat depot change to the response of plasma 25(OH)D levels. Another strength is the availability of the detailed diet information for participants in the lifestyle intervention. 13 This information has allowed us to conclude about the lack of univariate associations between changes in the integrative DASH-derived diet quality score, in the fatty fish consumption and in the dairy product consumption and changes in 25(OH)D. The current study has also the following limitations. First, only middle-aged French Canadian (Caucasian) men were studied limiting the external validity of the results to other ethnic groups, women and other age groups. Nevertheless and as described above, the association between 25(OH)D and VAT has been described in other ethnic groups and in women. Sun exposure was not documented, this factor being a major modulator of circulating 25(OH)D levels. However, 1-year variations of 25(OH)D were analyzed, therefore minimizing the seasonal effect of sun exposure. The linear relationship between the quartile of adiposity loss and increase in circulating 25(OH)D levels supports the notion that the observed increase is largely mediated by adiposity reduction and is not an artefact due to sun exposition.
CONCLUSION
The present study not only confirms the well-documented association between adiposity and 25(OH)D, but also provides evidence that a reduction in adiposity through lifestyle modifications, especially visceral adiposity, leads to a proportional increase in circulating 25(OH)D levels in nonsupplemented viscerally obese men. Thus, targeting visceral adiposity through improved lifestyle habits may contribute to increase vitamin D levels.
